en n 14 97 pn n 14 97 pmortality at day 100all causes n 1 1.013 13.40.013nrm n 1 1.07 7.20.066100-day agvhdgrades ii n 33 34.046 47.40.013grades iiieiv n 15 15.524 24.70.033gut agvhd n 15 15.531 32.00.014skin agvhd n 44 45.849 50.50.49liver agvhd n 2 2.17 7.20.10100-day engraftmentneutrophil 0.5 gl n 96 99.095 98.90.10 platelets 20gl n 92 96.878 80.40.0001platelets 50gl n 87 91.675 78.10.0001growth factor requirements n  11 1135 360.0001transfusion needsred blood cells median iqr3 2e55 3e80.0001platelets median iqr5 3e911 6e220.0001 relapse at day 100 n 5 5.28 8.70.35 length of stay days median iqr28 25e4152 41e660.0001 infection d0-d30septicemia n 12 138 90.37viral infection n 20 2119 200.86oral mucositisgrade 1e4 n 89 9278 840.12grade 3e4 n 55 6348 620.90abbreviations agvhd acute graft versus host disease en enteral nutrition iqr interquartile range 25e75 nrm non relapse mortality pn parenteral nutrition.

itis worth noting that the two sets of pairs overlapped for all path- ological related parameters.mortality and morbidityin comparison to the pn group the en group featured a greaterlymphomas2 24 4other malignancies6 65 5non-malignant diseases7 77 7disease status n ns1st cr48 4942 432nd cr31 3234 3523rd cr3 33 3progressive disease7 78 8disease status n 0.78d100 os rate a p 14 0.013 99.0 vs. 86.4 and a trend to a lower d100 nrm rate p 14 0.066 1.0 vs. 7.2 b .cr or non-malignant disease or na90 9389 92incidences of agvhd were significantly lower for all grades c d  and the gut localization was reduced p0.014.among the en patients 28 cases 29 received a further sup-progressive disease7 78 8number of transplantation n nsfirst94 9794 97second3 33 3plement with pn in particular for vomiting n 14 14 for grades iiieiv intestinal agvhd n 14 11 and the rest for refusal of naso-gastric tube feeding n 14 3 .

similarly within the en patients the platelethla mismatch unrelated n 14 109 n 0.730 mismatch34 3532 33positive cytomegalovirus serology n 0.44conditioning regimens n with antithymoglobulin28 2930 310.72engraftment was better median engraftment platelets  50gl 23 vs. 29 days p0.021 for en only compared to enpn.furthermore hospital stay was shorter p  0.0001  for en group.groups did not differ for rates of incidence of agvhd localized at skin or liver level  for median delay for polynuclearinfused stem cell dose mnc median iqr 108 kg rbw for cord bloodnumber of cd34th cells infused median iqr 106kg rbw for bone marrow and pbscs0.9 0.5e4.80.6 0.4e10.104.4 2.5e6.94.0 2.4e5.70.21neutrophil engraftment f despite massive administration of growth factors in the pn group p  0.0001 and for bacterial and viral infections or oral mucositis whatever the grading .nutritional outcomethe duration of en nutritional support either strictly en or en supplemented by pn was significantly shorter p  0.0001 .compared to the pn group the weight loss at discharge and at d100 from the entrance was greater in the en group p  0.0001 and p 14 0.003  .

en n 14 97pn n 14 97 age years mean - sd10.1 - 4.79.5 - 4.7stem cell source n bone marrow73 7573 75cord blood22 2322 23peripheral blood stem cells2 22 2total body irradiation n 52 5452 54donor n identical sibling37 3837 38unrelated60 6260 62diagnosis n non-malignant diseases7 77 7malignant diseases90 9390 93 abbreviations sd standard deviation.z-score for healthy anthropometry parameters adjusted for agemean - sdweight0.8 - 1.70.8 - 1.60.91abbreviations cr complete remission en enteral nutrition iqr interquartile range 25e75 hla human leukocyte antigen mnc mononuclear cells ns non- significant pbscs peripheral blood stem cells pn parenteral nutrition rbw recipient body weight sd standard deviation.a comparison using generalized linear mixed model.b comparison using wilcoxon signed rank test.c comparison using linear mixed model.supplementation in en group was 26 13e38 kcalkgday for body weight until 10 kg 31 24e40 kcalkgday up to 20 kg 21 16e27 kcalkgday up to 40 kg and 15 10e20 kcalkgday above 40 kg median iqr.

lille inserm chu lille service de nutrition u995 - liric - lille inflammation research international center f-59000 lille francea r t i c l e i n f o article historyreceived 16 may 2017accepted 5 october 2017keywordsgraft versus host disease microbiota haematological disease nutritional status paediatricbone marrow transplantations u m m a r y there is no consensus on the type of nutritional support to introduce in children undergoing allogeneic stem cell transplantation allo-sct after myeloablative conditioning mac.this retrospective multicenter observational study compared the early administration of enteral nutrition en group n 14 97 versus parenteral nutrition pn group n 14 97 in such patients with matching for important covariates.

when we assessed the agvhdsex mismatch male recipient female donor n 28 5129 480.79incidence in patients under en only n 69 vs. the ones of en pn subgroup n 28 we noticed a lower incidence in the former group for grades iiieiv 10 vs. 29 p 0.032 as well as the gut form 6 vs. 39 p 0.0001.platelet engraftment was significantly better at either threshold e .

the matching was to be exact for the four qualitative prognosis variables and to get the shortest difference within -5 years for the age criteria.nutritional goalsfor all patients included in this study daily nutritional goals were determined based on patients' body weight 100 kcalkgday for patients up to 10 kg 1000 kcal 50 kcaladditional kgday up to20 kg 1500 kcal25 kcaladditional kgday up to 40 kg and 35 kcalkgday for patients heavier than including a minimum of1.5 g of proteinkgday.

for the 28 patients 29 who stopped en the causes for stopping en were acute severe gvhd 11 patients refusal 4 patients or intolerance symptoms such as nausea vomiting sensation of gastric distension 13 patients.

2. overall survival a cumulative incidences of non relapse mortality b cumulative incidences of grades ii to iv agvhd c and grades iii to iv agvhd d at d100 poly- nuclear neutrophil engraftment e or platelets engraftment f in enteral plain line and parenteral dotted line groups abbreviations en enteral nutrition agvhd acute graft versus disease host pnn polynuclear neutrophil.5 patients hyperglycaemia 6 patients veno-occlusive disease 11 patients or any severe complications responsible for rean- imation stay 5 patients.

patients andor parents provided informed written consent to authorize medical records to be used for research purposes.matching criteriaen patients were matched one-to-one with pn patients selected among the three centres.

it was extended to 100 when oral feeding ceased because of anorexia andor mucositis.en was discontinued as patients had engrafted and their oral intake accounted for no less than 60 of their needs.in case of poor digestive tolerance such as vomiting or severe grades iiieiv intestinal agvhd en was implemented with or fully substituted by pn where parenteral solutions were either custom- compounded hospital all-in-one mix for patients weighting 30 kg or commercial ready-to-use multi-chamber bags supple- mented in micronutrients for patients above 30 kg.

all rights reserved.comprehending the impact of the type of nutritional support on clinical outcome e.to compare the effects of en vs. pn on early outcome of pae- diatric patients undergoing mac allo-sct we first retrospectively created a multi-centre database of pairs matched for relevant covariates then assessed differences between estimated curves and biology data from each group.materials and methodspatientsfrom january 2003 to december 2013 all non-adult patients age  18 referred to lille university hospital to undergo a mac allo-sct were enrolled in the study.

in pn group pn was interrupted in 27 patients 31 for oedemafig.

1. flow chart of number of patients n pairing and nutritional support modalities onset and duration in days of enteral nutrition en and parenteral nutrition pn from graft to discharge expressed as median interquartile range 25e75.resultspatientsninety-seven matched pairs were extracted and analysedtable 1.2patient's characteristics and transplantation modalities.

no association was found between the type of nutritional support and engraftment length of stay or infections but it was a small cohort n 39 with a selection bias patients under pn were those who had a severe mucositis.in non-haematological fields en is also reported advantageous in adults by reducing the length of hospital stay and the rate of infectious and non infectious complications and in children by improving survival in intensive care unit .

